1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one
C25H29F3N6O — CID 167584984
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one
1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one (PubChem CID 167584984) has the molecular formula C25H29F3N6O and a molecular weight of 486.54 g/mol. Its IUPAC name is 1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one.
Molecular Properties
| Compound Name | 1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one |
|---|---|
| PubChem CID | 167584984 |
| Molecular Formula | C25H29F3N6O |
| Molecular Weight | 486.54 g/mol |
| Exact Mass | 486.24 |
| IUPAC Name | 1-[4-[[6-[cyclopropyl-[[4-(trifluoromethyl)phenyl]methyl]amino]purin-9-yl]methyl]piperidin-1-yl]propan-2-one |
| SMILES | CC(=O)CN1CCC(Cn2cnc3c(N(Cc4ccc(C(F)(F)F)cc4)C4CC4)ncnc32)CC1 |
| InChI | InChI=1S/C25H29F3N6O/c1-17(35)12-32-10-8-19(9-11-32)13-33-16-31-22-23(33)29-15-30-24(22)34(21-6-7-21)14-18-2-4-20(5-3-18)25(26,27)28/h2-5,15-16,19,21H,6-14H2,1H3 |
| InChIKey | YWYMZDJIBMNQAW-UHFFFAOYSA-N |
| XLogP | 4.32 |
| TPSA | 67.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.54 |
| LogP ≤ 5 | 4.32 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167584984 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.